NOVARTIS PHARMACEUTICALS CORPORATION v. Adesanya et al, No. 2:2021cv03402 - Document 23 (E.D. Pa. 2022)
Court Description: ORDER THAT THE BANKRUPTCY COURTS JULY 14, 2021 OPINION AND ORDER FINDING THE JUDGMENT IN THE NEW JERSEY ACTION NON-DISCHARGEABLE, WITH THE EXCEPTION OF $57,605, IS AFFIRMED. THE BANKRUPTCY COURTS SEPTEMBER 15, 2021 ORDER DENYING APPELLANTS MOTION TO STAY PENDING APPEAL IS AFFIRMED. SIGNED BY HONORABLE KAREN S. MARSTON ON 11/2/22. 11/2/22 ENTERED AND COPIES E-MAILED.(bw)
Download PDF
<![CDATA[
NOVARTIS PHARMACEUTICALS CORPORATION v. Adesanya et al Doc. 23 Case 2:21-cv-03402-KSM Document 23 Filed 11/02/22 Page 1 of 1 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA CIVIL ACTION NOVARTIS PHARMACEUTICALS, Plaintiff/Appellee, NO. 21-3402-KSM v. ADENEKAN OLA-OLUWA ADESANYA, et al., Defendants/Appellants. ORDER AND NOW this 2nd day of November, 2022, upon consideration of Appellants’ Initial Brief (Doc. No. 12), Appellee’s Response Brief (Doc. No. 15), Appellants’ Reply Brief (Doc. No. 20), and the record on appeal (see Doc. Nos. 12-1 through 12-12; Doc. No. 21), it is ORDERED as follows: 1. The bankruptcy court’s July 14, 2021 opinion and order finding the Judgment in the New Jersey Action nondischargeable, with the exception of $57,605, is AFFIRMED. 2. The bankruptcy court’s September 15, 2021 order denying Appellants’ motion to stay pending appeal is AFFIRMED. IT IS SO ORDERED. /s/Karen Spencer Marston ______________________________ KAREN SPENCER MARSTON, J. Dockets.Justia.com
]]>
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You
should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
